H4ZL:F:F-HSBC FTSE EPRA NAREIT Developed UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 20.37

Change

+0.13 (+0.62)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.28 (+1.02%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.46 (+0.90%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

+3.08 (+0.52%)

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.51 (+0.91%)

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.47B
VUAA:F Vanguard S&P 500 UCITS Acc

+2.06 (+1.97%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+6.73 (+6.72%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

+0.06 (+0.74%)

USD 40.89B
0ZC:F Zscaler Inc

+6.16 (+3.41%)

USD 37.92B

ETFs Containing H4ZL:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.00% 39% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.00% 39% F 53% F
Trailing 12 Months  
Capital Gain 18.27% 59% D- 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.27% 59% D- 61% D-
Trailing 5 Years  
Capital Gain -11.18% 16% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.18% 16% F 40% F
Average Annual (5 Year Horizon)  
Capital Gain 0.70% 37% F 45% F
Dividend Return 0.70% 35% F 40% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.01% 56% F 84% B
Risk Adjusted Return 5.80% 34% F 40% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.